227 related articles for article (PubMed ID: 1848625)
1. Effect of 5-hydroxytryptamine3 receptor agonists on phosphoinositides hydrolysis in the rat fronto-cingulate and entorhinal cortices.
Edwards E; Harkins K; Ashby CR; Wang RY
J Pharmacol Exp Ther; 1991 Mar; 256(3):1025-32. PubMed ID: 1848625
[TBL] [Abstract][Full Text] [Related]
2. (+/-)-1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane(DOI) and alpha-methyl-5-HT: 5-HT2 receptor agonistic action on phosphatidylinositol metabolism in the rat fronto-cingulate and entorhinal cortex.
Edwards E; Ashby CR; Wang RY
Neuropharmacology; 1992 Jul; 31(7):615-21. PubMed ID: 1407401
[TBL] [Abstract][Full Text] [Related]
3. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.
Dumuis A; Bouhelal R; Sebben M; Cory R; Bockaert J
Mol Pharmacol; 1988 Dec; 34(6):880-7. PubMed ID: 2849052
[TBL] [Abstract][Full Text] [Related]
4. Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro.
Germonpré PR; Joos GF; Pauwels RA
Br J Pharmacol; 1998 Apr; 123(8):1571-8. PubMed ID: 9605563
[TBL] [Abstract][Full Text] [Related]
5. 5-HT3-like receptors in the rat medial prefrontal cortex: an electrophysiological study.
Ashby CR; Minabe Y; Edwards E; Wang RY
Brain Res; 1991 Jun; 550(2):181-91. PubMed ID: 1679370
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the receptors involved in the 5-HT-induced excitation of canine antral longitudinal muscle.
Prins NH; Akkermans LM; Lefebvre RA; Schuurkes JA
Br J Pharmacol; 2001 Nov; 134(6):1351-9. PubMed ID: 11704657
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological properties of the receptor(s) involved in the 5-hydroxytryptamine-induced contraction of the feline middle cerebral artery.
Hamel E; Robert JP; Young AR; MacKenzie ET
J Pharmacol Exp Ther; 1989 Jun; 249(3):879-89. PubMed ID: 2732950
[TBL] [Abstract][Full Text] [Related]
8. 5-HT3-like receptors in the rat medial prefrontal cortex: further pharmacological characterization.
Edwards E; Hampton E; Ashby CR; Zhang J; Wang RY
Brain Res; 1996 Sep; 733(1):21-30. PubMed ID: 8891244
[TBL] [Abstract][Full Text] [Related]
9. Serotonin-induced contraction in porcine coronary artery: use of ergolines to support vascular 5-hydroxytryptamine2-receptor heterogeneity.
Cushing DJ; Cohen ML
J Pharmacol Exp Ther; 1993 Jan; 264(1):193-200. PubMed ID: 8423526
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of serotonin-stimulated phosphoinositide turnover in brain regions of the immature rat.
Claustre Y; Rouquier L; Scatton B
J Pharmacol Exp Ther; 1988 Mar; 244(3):1051-6. PubMed ID: 2855237
[TBL] [Abstract][Full Text] [Related]
11. Characterization of 5-HT3 and 'atypical' 5-HT receptors mediating guinea-pig ileal contractions in vitro.
Eglen RM; Swank SR; Walsh LK; Whiting RL
Br J Pharmacol; 1990 Nov; 101(3):513-20. PubMed ID: 2076474
[TBL] [Abstract][Full Text] [Related]
12. Effects of various serotonin receptor subtype-selective antagonists alone and on m-chlorophenylpiperazine-induced neuroendocrine changes in rats.
Aulakh CS; Hill JL; Murphy DL
J Pharmacol Exp Ther; 1992 Nov; 263(2):588-95. PubMed ID: 1432690
[TBL] [Abstract][Full Text] [Related]
13. 5-HT-induced transferrin production by choroid plexus epithelial cells in culture: role of 5-HT1c receptor.
Tsutsumi M; Sanders-Bush E
J Pharmacol Exp Ther; 1990 Jul; 254(1):253-7. PubMed ID: 2164094
[TBL] [Abstract][Full Text] [Related]
14. Release of endogenous dopamine by stimulation of 5-hydroxytryptamine3 receptors in rat striatum.
Blandina P; Goldfarb J; Craddock-Royal B; Green JP
J Pharmacol Exp Ther; 1989 Dec; 251(3):803-9. PubMed ID: 2600815
[TBL] [Abstract][Full Text] [Related]
15. Biochemical characterization of phosphoinositide hydrolysis stimulated by 5-HT3 receptor agonists.
Edwards E; Ashby CR; Wang RY
Neuroreport; 1992 Dec; 3(12):1081-4. PubMed ID: 1362896
[TBL] [Abstract][Full Text] [Related]
16. 5-Hydroxytryptamine2 receptors coupled to phospholipase C in rat aorta: modulation of phosphoinositide turnover by phorbol ester.
Roth BL; Nakaki T; Chuang DM; Costa E
J Pharmacol Exp Ther; 1986 Aug; 238(2):480-5. PubMed ID: 3016238
[TBL] [Abstract][Full Text] [Related]
17. Characterization of YM060, a potent and selective 5-hydroxytryptamine3 receptor antagonist, in rabbit nodose ganglion and N1E-115 neuroblastoma cells.
Ito H; Hidaka K; Miyata K; Kamato T; Nishida A; Honda K
J Pharmacol Exp Ther; 1992 Dec; 263(3):1127-32. PubMed ID: 1469624
[TBL] [Abstract][Full Text] [Related]
18. Characterization of serotonin receptors in isolated rat intramyocardial coronary artery.
Lai FM; Tanikella T; Cervoni P
J Pharmacol Exp Ther; 1991 Jan; 256(1):164-8. PubMed ID: 1988655
[TBL] [Abstract][Full Text] [Related]
19. Serotonergic modulation of the release of endogenous norepinephrine from rat hypothalamic slices.
Blandina P; Goldfarb J; Walcott J; Green JP
J Pharmacol Exp Ther; 1991 Jan; 256(1):341-7. PubMed ID: 1988665
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of 5-hydroxytryptamine-induced apnea in the rat.
Yoshioka M; Goda Y; Togashi H; Matsumoto M; Saito H
J Pharmacol Exp Ther; 1992 Feb; 260(2):917-24. PubMed ID: 1531363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
